Atlas Trials

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Clinical trial NCT00234000 · TERMINATED

Trial details

NCT number
NCT00234000
Sponsor
Jonsson Comprehensive Cancer Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
LeukemiaMyelodysplastic Syndromes
Start date
2007-02-01
Primary completion
2009-02-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.